MediCare Announces Agenda of Its AGM and EGM Meetings to be Held on 31/03/2019

March 10, 2019

MediCare Group announced that its Board of Directors has the pleasure to invite shareholders to attend the Ordinary and Extraordinary General Assembly meetings that will be held at 5pm, Sunday 31st of March 2019, at “Emerald Hall”, Entrance No. 3 of Ezdan Towers Al-Dafna – West Bay Area. In case the quorum was not met for either meetings, the alternative meeting will be held on Sunday 7th April 2019, at 6:30pm in the same venue. The assembly will discuss the below agenda:

 

Agenda of the Ordinary General Meeting:

1.      Hear and endorse the Chairman’s keynote speech and the Board of Director’s report on the company’s activities and its financial position during the financial year ended 31/12/2018; and discuss future business plan.

 

2.      Hear and endorse the External Auditor’s report on the company’s consolidated financial statement for the financial year ended on 31/12/2018.

 

3.      Discuss and approve the company’s consolidated financial statement for the financial year ended on 31/12/2018.

 

4.      Approve the Board of Director’s recommendation for distributing cash dividends of 30 % of nominal share value (i.e. QR 3 per share).

 

5.      Absolve and release the Board of Directors from any liability for the financial year ended 31/12/018; and determine their remuneration.

 

6.      Review and approve the company’s Governance Report for the year 2018.

 

7.      Present the tender to appoint the External Auditors for the year 2019 and determine their fees.

 

8.      Approve the recommendation of the Board of Directors to allocate an amount of QR 1 million to treat patients in need who cannot afford the costs of treatment, and delegate to the Board of Directors the right to manage this amount and set the terms and conditions of eligibility.

 

Agenda of the Extraordinary General Meeting:

1.      Approve the recommendation of the Board of Directors to extend the duration of the company for a period of (50) years commencing from the end of the current period of the company on 02/02/2020.

 

2.      Approve the reduction of the nominal share value from QR 10 (Ten Qatari Riyals) to QR 1 (only One Qatari Riyal) to complying with the decision of the Board of Directors of Qatar Financial Markets Authority(QFMA) issued on 16/12/2018, and amend the relevant articles in the company's Article of Association to reflect this amendment.

 

3.      Grant the Chairman of the Board of Directors and/or His Deputy the exclusive right to sign the amended Articles of Association, and take all necessary proceedings to implement the decisions of the Extraordinary General Assembly meeting and complete the procedures of publishing the amendments in the Official Gazette.